The China-based research conducted annual follow-ups with COVID-19 patients admitted to a Wuhan hospital between Jan. 7, 2020, and May 29, 2020. Of the 1,359 patients, 56% had at least one sequelae symptom, or long COVID.
As infections spiked when the omicron variant heavily circulated, the two-year checkup found a higher proportion of reinfection among long COVID patients, 76%, compared to 67% of those who did not have sequelae symptoms.
The prevalence of pneumonia was also higher among long COVID patients, with 5% experiencing pneumonia versus 2%.
Three months after omicron infection, 62% of long COVID two years-post initial infection had new or worse symptoms. Among the non-long COVID group, this rate was 41%.
The researchers concluded that “severe long COVID symptoms, abnormal organ function or limited mobility require urgent attention in future clinical practice and research.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
